An independent test report is only useful if it belongs to the material in front of you. Contract research teams routinely receive suppliers’ claims about purity, identity and contaminant screening, but a claim is not a data package. The practical task is to move from the headline statement to the actual document, then from the document to the specific batch, and finally to your own laboratory records. This guide sets out what to verify, using Research Sciences’ published wording where relevant. All materials described are research-use-only and are not for human or veterinary use.
Trace the Claim Back to the Specific Batch Document
Independent testing claims often sit on a homepage or product page. For a contract research team, the claim must resolve to a certificate of analysis (CoA) tied to a batch, not a generic example. Research Sciences states that every product includes a CoA (HPLC) for purity and identity, and the homepage lists “CoAs Janoshik Analytical Reports”; treat those as the shop’s published wording and reconfirm the current position on the live site and on the batch document itself.
Start with identifiers. A usable report names the material, catalogue code, batch or lot reference, the laboratory that performed the analysis, the method used and the date of analysis. Dates should be read as month and year, not assumed. Check that the identifier on the report matches the vial label. Labels use a reference format combining SKU code and expiry date, such as BPC10-03/27, which links to the corresponding CoA. Quote that reference when contacting the shop about documentation.
Understand the Internal Test Reference (ITR). The FAQs say restocked products may carry the same ITR as earlier stock; an ITR links to associated sample testing reports but does not confirm that separate deliveries come from the same production lot or have had separate independent testing. That distinction matters in a contract research environment, where lot-to-lot traceability often determines whether data can be pooled. Vial cap colour and packaging may vary and are not indicators of identity, analytical quality or manufacturing origin.
If the report cannot be matched to the batch, treat it as a documentation gap. Ask for the correct document in writing, record the response and do not release the material into a study until the gap is closed.
Questions worth asking before acceptance
Which batch does this report cover? Was the sample drawn from that batch? Who commissioned the test? Is the full chromatogram available? Has the material been retested or the report amended? The answers should be consistent with the CoA and with the product listing.
Read the Analytical Content, Not Just the Headline Purity
Purity is where marketing language and analytical reality most often diverge. A stated figure such as “≥99% Verified Purity” or “UK Research Materials Over 99.1% Purity” is the shop’s published wording, not an independently audited result for every batch. The FAQs say peptides are typically supplied at ≥99% purity by HPLC and that the exact purity is stated on the CoA. For a contract team, the number that matters is the one on the report attached to the batch you hold.
Read the method. An HPLC purity result should be interpretable: column and mobile phase, gradient, detection wavelength, integration approach and the chromatogram itself. Without method detail, a percentage is difficult to compare across batches or suppliers. Identity confirmation should also be explicit; a purity figure alone does not establish that the material is what the label says. Where the CoA reports identity by an appropriate technique, check that the stated result and the supporting data are present.
Contaminant screening deserves the same scrutiny. Research Sciences describes an expanded testing framework with heavy metals and endotoxin screening alongside CoA documentation, and site guidance discusses ICP-MS and endotoxin testing. On the actual report, look for the method, the result and the acceptance criterion. If the report says “conforms” without a stated limit, ask what limit was applied. Do not infer a pass/fail threshold that is not printed on the document.
Formulation matters too. The FAQs state that all peptides contain trace amounts of mannitol as an excipient. That is relevant when interpreting purity and identity data and when planning in-vitro diluent volumes. The shop also says it does not supply blended peptides and recommends buying individual items and combining only within a controlled experimental design; single-vial documentation is generally easier to trace than a blended claim. For assay planning, reconstitution should be described only as a laboratory step: diluent volume and target concentration for the in-vitro system, with the shop’s calculator and materials explicitly not for medical or clinical use.
Check Provenance, Version Control and the Paper Trail
A report is a record, so treat it like one. Note who manufactured the material, who tested it and who released it. Research Sciences states that compounds are made by international partners using solid-phase peptide synthesis, independently tested by HPLC and subject to final verification and quality checks in the UK before release. Those statements should be read alongside the batch CoA, not instead of it.
Check dates and version history. The date of analysis, the date of release and the expiry on the label are different facts. Reconstituted material is less stable and, per the FAQ quick guide, should be stored at 2–8°C for short-term laboratory use; lyophilised material at −20°C or below, sealed with desiccant and protected from moisture, heat and light. None of that belongs in a clinical or veterinary context. Materials are not for human or veterinary use, and handling must follow COSHH and local laboratory safety standards.
Build the link between supplier documentation and your own records. Reference the CoA identifier, the vial reference and the study code in your laboratory information management system or electronic lab notebook. Keep the report version you assessed, and record any query and response. If your team is comparing items across a study, review the live catalogue before committing: researchers can use the category page to Buy peptides uk listings, then open each product page and its batch CoA for the specific documentation. Reconfirm the current wording, purity figure and dispatch terms on the live site rather than relying on a saved page.
Finally, ask for clarification in writing when something does not reconcile — a different batch code, a missing method, an ITR that cannot be tied to the delivery. A contract research team’s credibility rests on being able to show that the material used in an experiment was the material described in the report. That paper trail is the real deliverable behind any independent testing claim.
